Covered recipient · General Payments record
RACHEL D DAVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,186.13
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $564.46 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $185.38 | 19 |
| Novo Nordisk AS | $175.06 | 9 |
| Sumitomo Pharma America, Inc. | $119.55 | 1 |
| Gilead Sciences, Inc. | $22.02 | 1 |
| Medtronic, Inc. | $16.94 | 1 |
| Astellas Pharma US Inc | $16.34 | 1 |
| Acerta Pharma LLC | $15.85 | 1 |
| PFIZER INC. | $13.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1.45 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995516 | CMS |
| ABBVIE INC. | $4.63 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995518 | CMS |
| ABBVIE INC. | $11.83 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995520 | CMS |
| ABBVIE INC. | $31.25 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995522 | CMS |
| ABBVIE INC. | $7.32 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995524 | CMS |
| ABBVIE INC. | $10.36 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995526 | CMS |
| ABBVIE INC. | $6.68 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995528 | CMS |
| ABBVIE INC. | $16.27 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995530 | CMS |
| ABBVIE INC. | $3.21 | 07/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995532 | CMS |
| ABBVIE INC. | $4.89 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995534 | CMS |
| ABBVIE INC. | $12.60 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995536 | CMS |
| ABBVIE INC. | $3.86 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995538 | CMS |
| ABBVIE INC. | $9.63 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995540 | CMS |
| ABBVIE INC. | $3.12 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995542 | CMS |
| ABBVIE INC. | $22.72 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995544 | CMS |
| ABBVIE INC. | $15.01 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995546 | CMS |
| ABBVIE INC. | $4.71 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995548 | CMS |
| ABBVIE INC. | $11.86 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995550 | CMS |
| ABBVIE INC. | $3.98 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106995552 | CMS |
| Astellas Pharma US Inc | $16.34 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139554893 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.85 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105757727 | CMS |
| Gilead Sciences, Inc. | $22.02 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133681248 | CMS |
| Medtronic, Inc. | $16.94 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116986716 | CMS |
| Novo Nordisk Inc | $19.19 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100364981 | CMS |
| Novo Nordisk Inc | $19.38 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550498 | CMS |
| Novo Nordisk Inc | $13.75 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100291246 | CMS |
| Novo Nordisk Inc | $21.95 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100358610 | CMS |
| Novo Nordisk Inc | $19.96 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100488863 | CMS |
| Novo Nordisk Inc | $20.09 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100251294 | CMS |
| Novo Nordisk Inc | $19.43 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100269148 | CMS |
| Novo Nordisk Inc | $17.87 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100514145 | CMS |
| Novo Nordisk Inc | $23.44 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100426322 | CMS |
| PFIZER INC. | $13.32 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132032949 | CMS |
| Sumitomo Pharma America, Inc. | $119.55 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148954808 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.